ArticleJournal of virology2008

CAPERalpha is a novel Rel-TAD-interacting factor that inhibits lymphocyte transformation by the potent Rel/NF-kappaB oncoprotein v-Rel.

Jui Dutta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.